Skip to main content
Friday, September 25, 2026
Media Alert Press Media Alert Press Verify a URL
Live
Comedian Pretty Vee Signs With HeartRock For ManagementAdam Brody Declares Support For “Free Palestine” Ahead Of ‘Nobody Wants This’ Season 3‘Adults’ Star Rachel Marsh On Creating “Hiccup” Pop Anthem With Director: “We Tried All Different Versions”STAT+: Pharmalittle: We’re reading about a reticent FDA commish nominee, a Novo deal, and moreSTAT+: Up and down the ladder: The latest comings and goingsOpinion: FDA commissioner nominee Heidi Overton is ignoring the science on abortion drugComedian Pretty Vee Signs With HeartRock For ManagementAdam Brody Declares Support For “Free Palestine” Ahead Of ‘Nobody Wants This’ Season 3‘Adults’ Star Rachel Marsh On Creating “Hiccup” Pop Anthem With Director: “We Tried All Different Versions”STAT+: Pharmalittle: We’re reading about a reticent FDA commish nominee, a Novo deal, and moreSTAT+: Up and down the ladder: The latest comings and goingsOpinion: FDA commissioner nominee Heidi Overton is ignoring the science on abortion drug
Healthcare

Opinion: FDA commissioner nominee Heidi Overton is ignoring the science on abortion drug

By Julie F. Kay STAT News

MAP Verified Summary — reported by STAT News

“With this latest appointment, mifepristone has a new boss but an old problem,” writes Julie F. Kay, founder and CEO of Reproductive Futures.

This story’s context record documents 7 observable dimensions — Origin, Attribution, Specificity, Timing, Framing, Context Change, and Information Relationships — as part of Media Alert Press’s context-documentation ledger. MAP does not score or rate this content. Read the full original story at STAT News →

Discover more from Media Alert Press

Subscribe to get the latest posts sent to your email.

Original Source

This article was syndicated from STAT News. All rights remain with the original publisher.

Powered by